Uncategorized
Wegovy, the weight-loss medication, gets FDA approval for use as heart disease prevention drug
Barbara Ryan Advisors founder Barbara Ryan discusses the future of the biotech sector on ‘Making Money.’
Wegovy has been approved for use as a heart disease prevention medication, the FDA announced on Friday.
The injectable semaglutide — originally approved for weight loss for certain patients — is now also indicated to reduce the risk of cardiovascular death, heart attack and stroke in adults who have cardiovascular disease and are either overweight or obese, the announcement stated.
“Wegovy is now the first weight-loss medication to also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity or overweight,” said John Sharretts, M.D., director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDA’s Center for Drug Evaluation and Research, in the press release.
NOVO NORDISK CEO SAYS FOOD EXECS ARE ‘SCARED’ OF WEIGHT-LOSS DRUG THREAT
“This patient population has a higher risk of cardiovascular death, heart attack and stroke,” he also said.
“Providing a treatment option that is proven to lower this cardiovascular risk is a major advance for public health.”
Novo Nordisk’s blockbuster obesity medicine, Wegovy, reduced the risk of heart attacks and strokes in a highly anticipated study. (Carsten Snejbjerg/Bloomberg via Getty Images / Getty Images)
Wegovy, which is made by Denmark-based Novo Nordisk, is a glucagon-like peptide-1 (GLP-1) receptor agonist that should not be taken with other semaglutide or GLP-1 products, the FDA stated.
The approval comes after a large, randomized, double-blind trial that included 17,600 participants in two groups.
Both groups received “standard-of-care medical treatment (e.g., management of blood pressure and cholesterol) and healthy lifestyle counseling (including diet and physical activity).”
DIABETES-RELATED WEIGHT-LOSS DRUGS FACING SUPPLY ISSUES AMID VIRAL TREND
In the trial, the group that took Wegovy showed a significant reduction in cardiovascular death, heart attack and stroke.
Brooke Boyarsky Pratt, the CEO of knownwell, a Boston-based weight management company, said the announcement marked “an exciting day” for patients with heart disease as well as their doctors.
“This approval is an important step in getting patients access to potentially life-saving medication,” Pratt said in a statement to Fox News Digital.
The injectable semaglutide Wegovy was originally approved for weight loss for eligible patients. (Steffen Trumpf/picture alliance via Getty Images / Getty Images)
“It continues to support what the medical community has known all along — GLP-1s are here to treat serious chronic diseases, now cardiovascular disease in addition to diabetes and obesity.”
The FDA’s approval is a step in the right direction toward battling the “bias and stigma” around these medications, she said.
“Significantly reducing the risk of cardiac disease in patients who are at a higher risk is incredibly important to both patients and clinicians,” Pratt went on.
This is a “landmark decision in the field of medical therapy for obesity.”
“We hope that with this indication, these patients who unfortunately may not have had coverage for these medications before will soon find them covered.”
WEIGHT-LOSS MEDICATION SHORTAGE CREATES MARKET FOR BOGUS DRUGS
Dr. Darren McGuire, a cardiologist at UT Southwestern in Dallas, Texas, called the FDA’s approval a “landmark decision in the field of medical therapy for obesity.”
He told Fox News Digital, “With this FDA action, semaglutide becomes the first medication ever in the U.S. approved for the treatment of persons living with obesity with anything beyond a claim of cardiovascular safety.”
A general view of the headquarters of Danish pharmaceutical company Novo Nordisk in Copenhagen, Denmark, on Sept. 26, 2023. (REUTERS/Tom Little/File photo / Reuters Photos)
The decision, McGuire said, reinforces what most medical experts have known for decades — “that reducing body weight for persons living with obesity would reduce risk for a broad spectrum of obesity-related complications, cardiovascular and otherwise.”
GET FOX BUSINESS ON THE GO BY CLICKING HERE
McGuire, who is an expert in heart disease and prevention, especially among people with diabetes, predicts that approximately one in five U.S. adults would benefit from treatment with semaglutide.
“Conservatively, around 55 million U.S. adults have an indication for cardiovascular risk reduction with semaglutide,” he said.
Looking ahead, McGuire predicts that many similar medications will enter the market in years to come.
FDA CHIEF SOUNDS ALARM OVER SALE OF FAKE WEIGHT-LOSS DRUGS CIRCULATING ONLINE
“Presently, semaglutide is only one drug in one class with proof of cardiovascular efficacy and with FDA approval for such,” he told Fox News Digital. “Many more medications are presently being developed and tested similarly, so this field will rapidly evolve.”
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Patients should speak with a health care provider about the potential benefits and side effects of Wegovy, experts say.
Fox News Digital reached out to Novo Nordisk requesting additional comment.
Product Name: Urgent Money Miracle – $2+ EPC! Get Instant 90% Commission Bump
All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors.
Urgent Money Miracle – $2+ EPC! Get Instant 90% Commission Bump is backed with a 60 Day No Questions Asked Money Back Guarantee. If within the first 60 days of receipt you are not satisfied with Wake Up Lean™, you can request a refund by sending an email to the address given inside the product and we will immediately refund your entire purchase price, with no questions asked.
Product Name: NEW! Christian Wealth Manifestation – Highly Targeted For Christians!
All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors.
NEW! Christian Wealth Manifestation – Highly Targeted For Christians! is backed with a 60 Day No Questions Asked Money Back Guarantee. If within the first 60 days of receipt you are not satisfied with Wake Up Lean™, you can request a refund by sending an email to the address given inside the product and we will immediately refund your entire purchase price, with no questions asked.
As we look ahead to 2024, many homeowners and prospective buyers are wondering what to expect when it comes to mortgage rates. The landscape of the housing market is constantly changing, so it’s important to stay informed about trends and predictions. In this blog post, we will discuss some factors that could impact mortgage rates in 2024 and what homeowners and buyers can expect.
One factor that could impact mortgage rates in 2024 is the overall state of the economy. If the economy is strong and growing, we may see higher mortgage rates as the Federal Reserve looks to combat inflation. On the other hand, if the economy is stagnant or in a recession, we may see lower mortgage rates as the Fed looks to stimulate growth. It’s important to keep an eye on economic indicators such as GDP growth, unemployment rates, and inflation to get a sense of where mortgage rates may be heading.
Another factor that could impact mortgage rates in 2024 is Federal Reserve policy. The Fed plays a key role in setting interest rates, and their decisions can have a ripple effect on mortgage rates. If the Fed decides to raise interest rates in response to inflation, we may see an increase in mortgage rates. Conversely, if the Fed decides to lower interest rates to stimulate growth, we may see a decrease in mortgage rates. Keeping up with the latest news and announcements from the Fed can give homeowners and buyers a sense of where mortgage rates may be heading.
In terms of specific cities and local mortgage companies, it’s important to note that mortgage rates can vary depending on location and lender. For example, in a city like New York City, where real estate prices are high, mortgage rates may be higher compared to a city like Indianapolis, where real estate prices are lower. Additionally, local mortgage companies may offer competitive rates and terms compared to national lenders. For example, in New York City, local lenders like Quontic Bank and CrossCountry Mortgage may offer specialized products and services tailored to the needs of local buyers.
It’s important for homeowners and buyers to shop around and compare rates from multiple lenders to ensure they are getting the best deal. Websites like Bankrate and LendingTree can be helpful resources for comparing rates and terms from multiple lenders. Homeowners and buyers should also consider working with a mortgage broker who can help them navigate the lending process and find the best mortgage product for their needs.
In conclusion, predicting mortgage rates in 2024 is not an exact science, but there are several factors that could impact rates. By staying informed about economic indicators, Federal Reserve policy, and local market trends, homeowners and buyers can make informed decisions about their mortgage. Shopping around and comparing rates from multiple lenders is key to ensuring you are getting the best deal on your mortgage. Whether you’re looking to refinance your existing mortgage or buy a new home, it’s important to stay informed and be proactive in managing your mortgage.
-
Reverse Mortgage8 months agoHow Reverse Loans Can Provide Financial Relief in Retirement
-
Mortgage Rates8 months agoComo puedo comprar una casa a crédito si no se nada?
-
Reverse Mortgage8 months agoThe Pros and Cons of Using a Reverse Mortgage for Retirement Planning
-
Mortgage Rates8 months agoNiro Loan App 2024 || Niro App Se Loan Kaise Le || New Loan App Best Instant Loan App Without Cibi
-
Reverse Mortgage8 months agoExploring the Myths and Realities of Reverse Mortgages for Seniors in 2024
-
Reverse Mortgage8 months agoUnlocking Your Home’s Value: Everything You Need to Know About HECM Loans
-
USDA Mortgage6 months agoMaking Your Dream of Country Living a Reality: FMHA Rural Home Loans in Focus
-
Reverse Mortgage8 months agoIs a HECM the Right Choice for You? Exploring the Pros and Cons